Prescribing Controlled Substances via Telemedicine

Prescribing Controlled Substances via Telemedicine

Coordinated by the ATA Telemental Health Special Interest Group

Can doctors prescribe controlled substances via telemedicine?  The rules and regulations surrounding the prescription of controlled substances via telemedicine can seem confusing.  Fear and uncertainty about these rules results in the failure of telemedicine to reach populations in areas of addiction, mental health and pain management.  This course will provide a framework for interpreting the rules and regulations surrounding the prescription of controlled substances via telemedicine.  This course features a discussion/Q&A with the Chief of Policy at the DEA Office of Diversion Control, as well as luminaries in the field of telemedicine.  Never has a short course been so important.  This is a can’t miss event!

Learning Objectives 

  • Describe the way controlled substances are defined and categorized by the DEA.

  • Develop a framework for interpreting the rules and regulations governing the prescription of controlled substances via telemedicine.

  • Understand the history of the Ryan Haight Act and its ramifications on telemedicine.

  • Gain perspective on how the DEA approaches the practice of telemedicine. 

  • Apply an understanding of the rules and regulations surrounding controlled substance to telehealth practice.

Return to Pre-Conference Certificate Courses

Register to Attend


Moderator

Edward Kaftarian, MD
Chief of Telepsychiatry
California Correctional Healthcare Services

Faculty

Peter Yellowlees, MD, MBBS
Professor of Psychiatry
UC Davis

Donald Hilty, MD
Professor and Vice Chair of Education
Keck School of Medicine of USC

Thomas Kim, MD, MPH
Chief Medical Officer
Med 2 You

Elizabeth Brooks, PhD
Assistant Professor
Colorado School of Public Health

Janelle Wesloh, LADC, MBA
Executive Director of Recovery Management
Hazelden Betty Ford Foundation

Robert Caudill, MD
Associate Professor
Director, Psychiatry Resident Training Program
Director, Telemedicine & Information
Technology Programs
University of Louisville School of Medicine

Nina M. Antoniotti, RN, MBA, PhD
Executive Director of Telehealth and Clinical Outreach
SIU School of Medicine

Jim Arnold, Chief of Policy
Office of Diversion Control, Dea

Janelle Wesloh, LADC, MBA
Executive Director of Recovery Management
Hazelden Betty Ford Foundation

Kathleen Myers, MD, MPH, MS
Professor, University of Washington
Director, Telemental Health Service
Seattle Children's

Marlene Maheu, PhD
Executive Director
Telemental Health Institute

Jonathan White, MA, LPC
AVP Access & Referral Management
Telemecicine BHS
HCA Behavioral Health Services

Gary Capistrant
Chief Policy Officer
American Telemedicine Association

Latoya Thomas
Director, State Policy Resource Center
American Telemedicine Association